Arbutus Biopharma (ABUS) Short Interest Ratio & Short Volume $3.13 -0.11 (-3.40%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$3.21 +0.08 (+2.43%) As of 08:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arbutus Biopharma Short Interest DataArbutus Biopharma (ABUS) has a short interest of 13.77 million shares, representing 9.02% of the float (the number of shares available for trading by the public). This marks a 7.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 15.5, indicating that it would take 15.5 days of the average trading volume of 948,755 shares to cover all short positions.Current Short Interest13,770,000 sharesPrevious Short Interest12,840,000 sharesChange Vs. Previous Month+7.24%Dollar Volume Sold Short$42.55 millionShort Interest Ratio15.5 Days to CoverLast Record DateJune 30, 2025Outstanding Shares191,527,000 sharesShort Percent of Float9.02%Today's Trading Volume569,267 sharesAverage Trading Volume948,755 sharesToday's Volume Vs. Average60% Short Selling Arbutus Biopharma? Sign up to receive the latest short interest report for Arbutus Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartABUS Short Interest Over TimeABUS Days to Cover Over TimeABUS Percentage of Float Shorted Over Time Arbutus Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202513,770,000 shares $42.55 million +7.2%9.0%15.5 $3.09 6/15/202512,840,000 shares $45.33 million +0.7%8.4%13.8 $3.53 5/31/202512,750,000 shares $42.84 million +10.9%7.0%13.5 $3.36 5/15/202511,500,000 shares $35.88 million +2.8%6.3%10.7 $3.12 4/30/202511,190,000 shares $39.72 million +1.3%N/A10.9 $3.55 4/15/202511,050,000 shares $34.92 million +12.2%6.1%11.1 $3.16 3/31/20259,850,000 shares $34.38 million +2.9%5.4%10.1 $3.49 3/15/20259,570,000 shares $31.58 million +13.8%5.3%10.9 $3.30 2/28/20258,410,000 shares $29.01 million +16.6%4.6%9.8 $3.45 2/15/20257,210,000 shares $23.72 million +7.3%4.0%8.8 $3.29 Get the Latest News and Ratings for ABUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20256,720,000 shares $22.38 million +1.2%N/A8.1 $3.33 1/15/20256,640,000 shares $21.78 million +11.6%N/A8 $3.28 12/31/20245,950,000 shares $19.46 million -0.3%N/A6.8 $3.27 12/15/20245,970,000 shares $20.78 million +2.6%N/A6.9 $3.48 11/30/20245,820,000 shares $20.14 million -4.0%N/A5.7 $3.46 11/15/20246,060,000 shares $22.06 million -7.3%N/A5.3 $3.64 10/31/20246,540,000 shares $25.15 million -16.1%N/A5.9 $3.85 10/15/20247,790,000 shares $32.02 million +5.8%N/A6.9 $4.11 9/30/20247,360,000 shares $28.34 million +12.2%N/A6.6 $3.85 9/15/20246,560,000 shares $29.32 million +8.3%N/A5.6 $4.47 8/31/20246,060,000 shares $23.45 million -8.7%N/A5.8 $3.87 8/15/20246,640,000 shares $24.90 million -2.4%N/A6.6 $3.75 7/31/20246,800,000 shares $25.64 million -3.1%N/A6.8 $3.77 7/15/20247,020,000 shares $26.33 million +16.8%N/A7.3 $3.75 6/30/20246,010,000 shares $18.57 million +11.9%N/A6.1 $3.09 6/15/20245,370,000 shares $16.86 million +6.8%N/A4.2 $3.14 5/31/20245,030,000 shares $16.90 million -5.8%N/A4.1 $3.36 5/15/20245,340,000 shares $15.01 million -8.1%N/A4.6 $2.81 4/30/20245,810,000 shares $15.86 million +12.4%N/A4.3 $2.73 4/15/20245,170,000 shares $15.35 million +13.6%N/A3.7 $2.97 3/31/20244,550,000 shares $11.74 million +10.2%N/A3.4 $2.58 3/15/20244,130,000 shares $10.82 million +1.5%N/A4.4 $2.62 2/29/20244,070,000 shares $11.40 million +10.3%N/A4.2 $2.80 2/15/20243,690,000 shares $10.74 million -39.7%N/A3.8 $2.91 1/31/20246,120,000 shares $14.50 million -4.8%N/A7.3 $2.37 1/15/20246,430,000 shares $14.85 million +3.4%N/A9.5 $2.31 12/31/20236,220,000 shares $15.55 million +0.5%N/A9.1 $2.50 12/15/20236,190,000 shares $13.87 million +0.2%N/A9.2 $2.24 11/30/20236,180,000 shares $12.67 million -8.2%N/A9.4 $2.05 11/15/20236,730,000 shares $12.38 million +6.7%N/A10.6 $1.84[ATTENTION] This Crypto Rocket Is About Launch… (Ad)Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.Join The Crypto Code Workshop + get $10 in Bitcoin for attending 10/31/20236,310,000 shares $11.55 million +9.4%N/A10.4 $1.83 10/15/20235,770,000 shares $10.73 million -16.1%N/A9.4 $1.86 9/30/20236,880,000 shares $13.97 million +18.6%N/A11.2 $2.03 9/15/20235,800,000 shares $11.83 million +12.0%N/A9.4 $2.04 8/31/20235,180,000 shares $10.52 million +0.8%N/A8.3 $2.03 8/15/20235,140,000 shares $10.23 million +5.1%N/A8.4 $1.99 7/31/20234,890,000 shares $10.61 million +0.8%N/A8.5 $2.17 7/15/20234,850,000 shares $10.82 million -0.8%N/A7.8 $2.23 6/30/20234,890,000 shares $11.25 million +12.7%N/A6.8 $2.30 6/15/20234,340,000 shares $10.59 million +2.1%N/A5.8 $2.44 5/31/20234,250,000 shares $10.58 million -0.9%N/A5.3 $2.49 5/15/20234,290,000 shares $10.98 million +8.3%N/A4.7 $2.56 4/30/20233,960,000 shares $9.94 million -7.0%N/A4.2 $2.51 4/15/20234,260,000 shares $12.23 million -13.9%N/A4.7 $2.87 3/31/20234,950,000 shares $15.00 million +5.5%N/A5.4 $3.03 3/15/20234,690,000 shares $14.21 million +15.8%N/A5 $3.03 2/28/20234,050,000 shares $11.26 million +1.5%N/A4.5 $2.78 2/15/20233,990,000 shares $10.85 million -7.4%N/A4.5 $2.72 1/31/20234,310,000 shares $12.97 million -8.5%N/A4.6 $3.01 1/15/20234,710,000 shares $13.42 million -0.6%N/A4.9 $2.85 12/30/20224,740,000 shares $11.04 million +23.1%N/A4.6 $2.33 12/15/20223,850,000 shares $10.43 million -4.0%N/A4.1 $2.71 11/30/20224,010,000 shares $9.42 million +7.2%N/A4.4 $2.35 11/15/20223,740,000 shares $10.43 million -10.3%N/A4.3 $2.79 10/31/20224,170,000 shares $9.76 million -0.7%N/A5.2 $2.34 10/15/20224,200,000 shares $9.20 million +2.2%N/A5.4 $2.19 9/30/20224,110,000 shares $7.85 million +7.6%N/A5.6 $1.91 9/15/20223,820,000 shares $8.82 million -2.6%N/A4.7 $2.31 8/31/20223,920,000 shares $8.70 million -11.1%N/A4.7 $2.22 8/15/20224,410,000 shares $11.16 million -7.4%N/A4.8 $2.53 7/31/20224,760,000 shares $11.00 million -7.4%N/A4.5 $2.31 7/15/20225,140,000 shares $13.06 million -2.5%N/A4.8 $2.54 6/30/20225,270,000 shares $14.28 million +7.1%N/A4.5 $2.71 6/15/20224,920,000 shares $12.55 million -7.9%N/A3.9 $2.55 5/31/20225,340,000 shares $12.98 million +6.6%N/A3.8 $2.43 5/15/20225,010,000 shares $11.57 million -5.8%N/A2.9 $2.31 4/30/20225,320,000 shares $12.40 million -8.3%N/A2.9 $2.33 4/15/20225,800,000 shares $15.95 million -12.8%N/A2.6 $2.75 3/31/20226,650,000 shares $19.82 million +0.3%N/A2.7 $2.98 3/15/20226,630,000 shares $18.96 million -8.8%N/A2.3 $2.86 2/28/20227,270,000 shares $23.26 million +3.0%N/A1.8 $3.20 2/15/20227,060,000 shares $22.95 million +4.1%N/A0.7 $3.25 1/31/20226,780,000 shares $19.05 million +73.0%N/A0.7 $2.81 1/15/20223,920,000 shares $12.98 million -13.9%N/A0.4 $3.31 12/31/20214,550,000 shares $17.70 million -43.6%N/A0.5 $3.89 12/15/20218,060,000 shares $32.97 million +253.5%N/A0.8 $4.09 11/30/20212,280,000 shares $7.30 million -4.2%N/A0.2 $3.20 11/15/20212,380,000 shares $8.00 million -15.0%N/A1 $3.36 10/29/20212,800,000 shares $11.28 million +0.7%N/A1.1 $4.03 10/15/20212,780,000 shares $11.34 million No Change3.5%1.1 $4.08[ATTENTION] This Crypto Rocket Is About Launch… (Ad)Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.Join The Crypto Code Workshop + get $10 in Bitcoin for attending 9/30/20212,780,000 shares $11.93 million -24.9%3.5%1.2 $4.29 9/15/20213,700,000 shares $15.61 million -6.1%4.6%1.6 $4.22 8/31/20213,940,000 shares $13.51 million -5.1%4.9%2.4 $3.43 8/13/20214,150,000 shares $12.74 million -26.2%5.2%2.5 $3.07 7/30/20215,620,000 shares $15.12 million +14.9%7.3%3.6 $2.69 7/15/20214,890,000 shares $12.96 million -9.6%6.3%3.1 $2.65 6/30/20215,410,000 shares $16.39 million +51.1%7.0%3.3 $3.03 6/15/20213,580,000 shares $11.38 million -14.4%4.6%2.8 $3.18 5/28/20214,180,000 shares $11.83 million -9.3%5.4%3.1 $2.83 5/14/20214,610,000 shares $11.53 million +19.4%N/A2.9 $2.50 4/30/20213,860,000 shares $13.55 million -8.5%N/A1.9 $3.51 4/15/20214,220,000 shares $14.01 million +1.9%N/A1.9 $3.32 3/31/20214,140,000 shares $13.04 million +6.2%N/A1.6 $3.15 3/15/20213,900,000 shares $14.78 million +19.3%N/A1.3 $3.79 2/26/20213,270,000 shares $12.46 million +28.2%N/A0.8 $3.81 2/12/20212,550,000 shares $11.17 million -20.1%N/A0.6 $4.38 1/29/20213,190,000 shares $11.71 million -21.2%N/A0.8 $3.67 1/15/20214,050,000 shares $16.32 million -16.0%N/A1.2 $4.03 12/31/20204,820,000 shares $17.93 million +63.4%N/A1.5 $3.72 12/15/20202,950,000 shares $14.40 million +37.9%N/A1 $4.88 11/30/20202,140,000 shares $9.29 million -2.3%N/A1.1 $4.34 11/15/20202,190,000 shares $7.95 million -17.7%N/A1.3 $3.63 10/30/20202,660,000 shares $7.82 million +32.3%N/A1.4 $2.94 10/15/20202,010,000 shares $6.35 million -36.2%N/A0.6 $3.16 9/30/20203,150,000 shares $9.86 million +4.7%N/A0.3 $3.13 9/15/20203,010,000 shares $8.85 million +14.9%N/A0.3 $2.94 8/31/20202,620,000 shares $7.62 million -0.8%N/A0.3 $2.91 8/14/20202,640,000 shares $9.16 million +34.0%N/A0.3 $3.47 7/31/20201,970,000 shares $7.51 million +157.5%3.9%0.2 $3.81 ABUS Short Interest - Frequently Asked Questions What is Arbutus Biopharma's current short interest? Short interest is the volume of Arbutus Biopharma shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 13,770,000 shares of ABUS short. 9.02% of Arbutus Biopharma's shares are currently sold short. Learn More on Arbutus Biopharma's current short interest. What is a good short interest ratio for Arbutus Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABUS shares currently have a short interest ratio of 16.0. Learn More on Arbutus Biopharma's short interest ratio. Which institutional investors are shorting Arbutus Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arbutus Biopharma: Jane Street Group LLC, Caption Management LLC, Nomura Holdings Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Arbutus Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.02% of Arbutus Biopharma's floating shares are currently sold short. Is Arbutus Biopharma's short interest increasing or decreasing? Arbutus Biopharma saw a increase in short interest in June. As of June 30th, there was short interest totaling 13,770,000 shares, an increase of 7.2% from the previous total of 12,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Arbutus Biopharma's short interest compare to its competitors? 9.02% of Arbutus Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Arbutus Biopharma: Bausch Health Cos Inc. (2.86%), Agios Pharmaceuticals, Inc. (6.83%), Twist Bioscience Corporation (0.05%), Indivior PLC (7.18%), Recursion Pharmaceuticals, Inc. (35.52%), Denali Therapeutics Inc. (9.91%), Beam Therapeutics Inc. (24.82%), Kiniksa Pharmaceuticals International, plc (6.10%), Belite Bio, Inc. Sponsored ADR (0.60%), Centessa Pharmaceuticals PLC Sponsored ADR (4.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Arbutus Biopharma stock? Short selling ABUS is an investing strategy that aims to generate trading profit from Arbutus Biopharma as its price is falling. ABUS shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arbutus Biopharma? A short squeeze for Arbutus Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABUS, which in turn drives the price of the stock up even further. How often is Arbutus Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABUS, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies BHC Short Squeeze AGIO Short Squeeze TWST Short Squeeze INDV Short Squeeze RXRX Short Squeeze DNLI Short Squeeze BEAM Short Squeeze KNSA Short Squeeze BLTE Short Squeeze CNTA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABUS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbutus Biopharma Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Arbutus Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABUS Stock Alerts